5.031 Jul 2025DirectorCurrent employeeLondon, EnglandRecommendCEO approvalBusiness outlookProsHuge client list across pharmaConsNeed more staff as we keep winning big tracker programmes.Show more
5.022 May 2023Research analystCurrent employeePhiladelphia, PARecommendCEO approvalBusiness outlookProsFlexibility, friendly and supportive colleagues, interesting projects.ConsNo downsides, I enjoy working at this company.Show moreHelpfulShare1
2.024 Sept 2024Associate directorCurrent employee, more than 3 yearsBlue Bell, PARecommendCEO approvalBusiness outlookProsI am able to work remotely so flexibility is good.ConsNew owners conducted major layoffsShow moreHelpfulShare1